Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Delobel

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
AIDS (London, England)|June 19, 2010
Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maravirocPierre Delobel, Stéphanie Raymond, Maud Mavigner, et al.
Journal of Neurology|May 28, 2004
Granulomatous angiitis of the central nervous system revealing Hodgkin's diseasePierre Delobel, David Brassat, Marie Danjoux, et al.
Journal of Viral Hepatitis|August 3, 2020
No evidence of sexual transmission of HEV among individuals using HIV pre-exposure prophylaxisMarion Migueres, Maïlys Ducours, Chloé Dimeglio, et al.
The Journal of Antimicrobial Chemotherapy|February 15, 2018
HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platformStéphanie Raymond, Florence Nicot, Romain Carcenac, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropismAdrien Saliou, Pierre Delobel, Martine Dubois, et al.
International Journal of Molecular Sciences|May 28, 2022
Severe Muscle Deconditioning Triggers Early Extracellular Matrix Remodeling and Resident Stem Cell Differentiation into Adipocytes in Healthy MenCorentin Guilhot, Théo Fovet, Pierre Delobel, et al.
Fundamental & Clinical Pharmacology|September 25, 2016
Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?David Metsu, Patrick Seraissol, Pierre Delobel, et al.
The Journal of Infection|December 22, 2016
HEV infection in French HIV-infected patientsFlorence Abravanel, Sébastien Lhomme, Mélanie Fougère, et al.
AIDS (London, England)|November 13, 2009
Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?Guillaume Martin-Blondel, Lise Cuzin, Pierre Delobel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 15, 2020
Prognostic value of residual vegetation after antibiotic treatment for infective endocarditis: A retrospective cohort studyValérie Houard, Lydie Porte, Clémence Delon, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
AIDS (London, England)|June 19, 2010
Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maravirocPierre Delobel, Stéphanie Raymond, Maud Mavigner, et al.
Journal of Neurology|May 28, 2004
Granulomatous angiitis of the central nervous system revealing Hodgkin's diseasePierre Delobel, David Brassat, Marie Danjoux, et al.
Journal of Viral Hepatitis|August 3, 2020
No evidence of sexual transmission of HEV among individuals using HIV pre-exposure prophylaxisMarion Migueres, Maïlys Ducours, Chloé Dimeglio, et al.
The Journal of Antimicrobial Chemotherapy|February 15, 2018
HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platformStéphanie Raymond, Florence Nicot, Romain Carcenac, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropismAdrien Saliou, Pierre Delobel, Martine Dubois, et al.
International Journal of Molecular Sciences|May 28, 2022
Severe Muscle Deconditioning Triggers Early Extracellular Matrix Remodeling and Resident Stem Cell Differentiation into Adipocytes in Healthy MenCorentin Guilhot, Théo Fovet, Pierre Delobel, et al.
Fundamental & Clinical Pharmacology|September 25, 2016
Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?David Metsu, Patrick Seraissol, Pierre Delobel, et al.
The Journal of Infection|December 22, 2016
HEV infection in French HIV-infected patientsFlorence Abravanel, Sébastien Lhomme, Mélanie Fougère, et al.
AIDS (London, England)|November 13, 2009
Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?Guillaume Martin-Blondel, Lise Cuzin, Pierre Delobel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 15, 2020
Prognostic value of residual vegetation after antibiotic treatment for infective endocarditis: A retrospective cohort studyValérie Houard, Lydie Porte, Clémence Delon, et al.
Pageof 16